Turn recording back on
CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis.
Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S, Nakshatri H.
Breast Cancer Res. 2006;8(5):R59.
PMID: 17062128 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C.
Breast Cancer Res. 2008;10(3):R53. Epub 2008 Jun 17.
PMID: 18559090 [PubMed - indexed for MEDLINE]
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L.
Breast Cancer Res. 2008;10(1):R10. Epub 2008 Feb 1.
PMID: 18241344 [PubMed - indexed for MEDLINE]
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.
Fillmore CM, Kuperwasser C.
Breast Cancer Res. 2008;10(2):R25. Epub 2008 Mar 26.
PMID: 18366788 [PubMed - indexed for MEDLINE]
Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity.
Hughes L, Malone C, Chumsri S, Burger AM, McDonnell S.
Clin Exp Metastasis. 2008;25(5):549-57. Epub 2008 Apr 2.
PMID: 18386134 [PubMed - indexed for MEDLINE]
Related Articles
[Detection of breast cancer stem cells and the expression of key molecules in Hedgehog signaling pathway]
Lu ZH, Jia J, Ren J, Ma B, DI LJ, Song GH.
Beijing Da Xue Xue Bao. 2008 Oct 18;40(5):480-5. Chinese.
PMID: 18931709 [PubMed - in process]
Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.
Breast Cancer Res. 2007;9(6):R76.
PMID: 17980029 [PubMed - indexed for MEDLINE]
CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL.
Br J Cancer. 2008 Feb 26;98(4):756-65. Epub 2008 Feb 12.
PMID: 18268494 [PubMed - indexed for MEDLINE]
Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma.
Huang P, Wang CY, Gou SM, Wu HS, Liu T, Xiong JX.
World J Gastroenterol. 2008 Jun 28;14(24):3903-7.
PMID: 18609717 [PubMed - indexed for MEDLINE]
High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, Allan AL.
J Cell Mol Med. 2008 Aug 4. [Epub ahead of print]
PMID: 18681906 [PubMed - as supplied by publisher]
The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
Mylona E, Giannopoulou I, Fasomytakis E, Nomikos A, Magkou C, Bakarakos P, Nakopoulou L.
Hum Pathol. 2008 Jul;39(7):1096-102. Epub 2008 May 20.
PMID: 18495204 [PubMed - indexed for MEDLINE]
A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
Ling LJ, Wang S, Liu XA, Shen EC, Ding Q, Lu C, Xu J, Cao QH, Zhu HQ, Wang F.
Chin Med J (Engl). 2008 Oct 20;121(20):1980-6.
PMID: 19080260 [PubMed - in process]
Differentially expressed genes associated with the metastatic phenotype in breast cancer.
Kirschmann DA, Seftor EA, Nieva DR, Mariano EA, Hendrix MJ.
Breast Cancer Res Treat. 1999 May;55(2):127-36.
PMID: 10481940 [PubMed - indexed for MEDLINE]
Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.
Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H.
Clin Cancer Res. 2005 Feb 1;11(3):1154-9.
PMID: 15709183 [PubMed - indexed for MEDLINE]
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells.
Grimshaw MJ, Cooper L, Papazisis K, Coleman JA, Bohnenkamp HR, Chiapero-Stanke L, Taylor-Papadimitriou J, Burchell JM.
Breast Cancer Res. 2008;10(3):R52. Epub 2008 Jun 9.
PMID: 18541018 [PubMed - indexed for MEDLINE]
The prognostic role of a gene signature from tumorigenic breast-cancer cells.
Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF.
N Engl J Med. 2007 Jan 18;356(3):217-26.
PMID: 17229949 [PubMed - indexed for MEDLINE]
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
Phillips TM, McBride WH, Pajonk F.
J Natl Cancer Inst. 2006 Dec 20;98(24):1777-85.
PMID: 17179479 [PubMed - indexed for MEDLINE]
CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells.
Schabath H, Runz S, Joumaa S, Altevogt P.
J Cell Sci. 2006 Jan 15;119(Pt 2):314-25. Epub 2006 Jan 3.
PMID: 16390867 [PubMed - indexed for MEDLINE]
Isolation of CD24(high) and CD24(low/-) cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7.
Kim HJ, Kim JB, Lee KM, Shin I, Han W, Ko E, Bae JY, Noh DY.
Cancer Lett. 2007 Dec 8;258(1):98-108.
PMID: 17950993 [PubMed - indexed for MEDLINE]
The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype.
Sung V, Gilles C, Murray A, Clarke R, Aaron AD, Azumi N, Thompson EW.
Exp Cell Res. 1998 Jun 15;241(2):273-84.
PMID: 9637769 [PubMed - indexed for MEDLINE]